HLB Therapeutics Co.,Ltd.
115450
Rang in aandelen
#18257
HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the... HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the creation of pharmaceutical products for both the South Korean and international markets. A significant part of its research and development initiatives includes GBT-201, a compound utilizing Thymosin beta designed to treat various eye ailments such as dry eye syndrome and neurotrophic keratopathy. Additionally, the company is advancing OKN-007 as a potential therapy for glioblastoma brain tumors. Beyond its pharmaceutical endeavors, HLB Therapeutics is also involved in the wholesale distribution of vaccines and the production of electrical and electronic components like motors, pumps, and transformers. The company, which established its roots in 2000 and is based in Seongnam, South Korea, underwent a name change in December 2021, transitioning from its former identity as G-treeBNT Co., Ltd. to its current designation.
Aandeelprijs
$2.02
Marktkapitalisatie
$190.66M
Verandering (1 dag)
7.96%
Verandering (1 jaar)
-1.16%
Land
KR
Handel HLB Therapeutics Co.,Ltd. (115450)
Categorie
Healthcare
Aandelsplitsingen voor HLB Therapeutics Co.,Ltd. (115450)
Het aandeel HLB Therapeutics Co.,Ltd. (symbool: 115450) heeft in totaal 6 splitsingen ondergaan.
De meest recente splitsing vond plaats op Mar 12, 2026.
Eén aandeel 115450 dat vóór Dec 18, 2013 werd gekocht, staat nu gelijk aan 1.49754041325 aandelen 115450.
De meest recente splitsing vond plaats op Mar 12, 2026.
Eén aandeel 115450 dat vóór Dec 18, 2013 werd gekocht, staat nu gelijk aan 1.49754041325 aandelen 115450.
Lijst van aandelen splitsingen
| Jaar | Splitsing | Vermenigvuldiging | Cumulatieve vermenigvuldiging |
|---|---|---|---|
| 2026-03-12 | 21:20 | x1.05 | x1.49754041325 |
| 2025-01-14 | 21:20 | x1.05 | x1.426228965 |
| 2023-12-27 | 207:200 | x1.035 | x1.3583133 |
| 2023-03-15 | 2:1 | x2 | x1.31238 |
| 2022-12-28 | 207:400 | x0.5175 | x0.65619 |
| 2013-12-18 | 317:250 | x1.268 | x1.268 |
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aantal aandelen splitsingen | Cumulatieve vermenigvuldiging | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
NL
|
|
| 0 | - |
CH
|
